Surface modification of liposomes using polymer-wheat germ agglutinin conjugates to improve the absorption of peptide drugs by pulmonary administration

Journal of Pharmaceutical Sciences

Volumn 102, Issue 4, 2013, Pages 1281-1289

  Murata, Mitsutaka ^a   Yonamine, Takashi ^a   Tanaka, Shota ^a   Tahara, Kohei ^a   Tozuka, Yuichi ^a,b   Takeuchi, Hirofumi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Bioadhesion; Lectin; Liposomes; Nanoparticles; Peptide; Polymer synthesis; Pulmonary delivery; Surface modification; Wheat germ agglutinin

Indexed keywords

CALCITONIN; CARBOMER; CYANAMIDE; LIPOSOME; WHEAT GERM AGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CYTOTOXICITY; DRUG ABSORPTION; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MALE; NONHUMAN; RAT;

EID: 84874686238     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23463     Document Type: Article

References (27)

1. Liu FY, Shao Z, Kildsig DO, Mitra AK. 1993. Pulmonary delivery of free and liposomal insulin. Pharm Res 10:228-232.
2. Patton JS. 1996. Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 19:3-36.
3. Beck-Broichsitter M, Merkel, OM, Kissel T. 2012. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Control Release 161:214-224.
4. Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N. 2001. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res 2:198-209.
5. Siekmeier R, Scheuch G. 2009. Treatment of systemic diseases by inhalation of biomolecule aerosols. J Physiol Pharmacol 60:15-26.
6. Stark B, Andreae F, Mosgoeller W, Edetsberger M, Gaubitzer E, Koehler G, Prassl R. 2008. Liposomal vasoactive intestinal peptide for lung application: Protection from proteolytic degradation. Eur J Pharm Biopharm 70:153-164.
7. Zhao L, Ye Y, Li J, Wei Y. 2011. Preparation and the in vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs. J Pharm Pharmacol 63:80-86.
8. Nakano K, Tozuka Y, Takeuchi H. 2008. Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells. Int J Pharm 354:174-179.
9. Yoshizawa Y, Kono Y, Ogawara K, Kimura T, Higaki K. 2011. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Int J Pharm 412:132-141.
10. Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. 2005. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303:160-170.
11. Murata M, Nakano K, Tahara K, Tozuka Y, Takeuchi H. 2012. Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: Polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers. Eur J Pharm Biopharm 80:340-346.
12. Cryan SA. 2005. Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J 7:20-41.
13. Goldstein IJ, Hayes CE. 1978. The lectins: Carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem 35:127-340.
14. Yi SM, Harson RE, Zabner J, Welsh MJ. 2002. Lectin binding and endocytosis at the apical surface of human airway epithelia. Gene Ther 8:1826-1832.
15. Sharma A, Sharma S, Khuller GK, 2004. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. J Antimicrob Chemother 54:761-766.
16. Makhlof A, Fujimoto S, Tozuka Y, Takeuchi H. 2011. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. Eur J Pharm Biopharm 77:216-224.
17. Werle M, Makhlof A, Takeuchi H. 2010. Carbopol-lectin conjugate coated liposomes for oral peptide delivery. Chem Pharm Bull 58:432-434.
18. Shahiwala A, Misra A. 2004. Nasal delivery of levonorgestrel for contraception: An experimental study in rats. Fertil Steril 81:893-898.
19. Ho W, Furst A. 1973. Intratracheal instillation method for mouse lungs. Oncology 27:385-393.
20. Yamada K, Odomi M, Okada N, Fujita T, Yamamoto A. 2005. Chitosan oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of interferon-α in rats. J Pharm Sci 94:2432-2440.
21. Henderson RF. 1984. Use of bronchoalveolar lavage to detect lung damage. Environ Health Perspect 56:115-129.
22. Surti N, Misra A. 2008. Wheat germ agglutinin-conjugated nanoparticles for sustained cellular and lung delivery of budesonide. Drug Deliv 15:81-86.
23. Bies C, Lehr CM, Woodley JF. 2004. Lectin-mediated drug targeting: History and applications. Adv Drug Deliv Rev 56:425-435.
24. Lehr CM. 2000. Lectin-mediated drug delivery: The second generation of bioadhesives. J Control Release 65:19-29.
25. Mo Y, Lim LY. 2004. Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. J Pharm Sci 93:20-28.
26. Abu-Dahab R, Schäfer UF, Lehr CM. 2001. Lectin-functionalized liposomes for pulmonary drug delivery: Effect of nebulization on stability and bioadhesion. Eur J Pharm Sci 14:37-46.
27. Brück A, Abu-Dahab R, Borchard G, Schäfer UF, Lehr CM. 2001. Lectin-functionalized liposomes for pulmonary drug delivery: Interaction with human alveolar epithelial cells. J Drug Target 9:241-251.